Detalhe da pesquisa
1.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
2.
T Cell-Activating Bispecific Antibodies in Cancer Therapy.
J Immunol
; 203(3): 585-592, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332079
3.
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas.
Blood Cancer J
; 14(1): 27, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331870
4.
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
Cancers (Basel)
; 16(8)2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672653
5.
Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma.
Leuk Lymphoma
; 64(14): 2217-2224, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933565
6.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv
; 7(16): 4528-4538, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026796
7.
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast.
Leuk Lymphoma
; 63(3): 591-598, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672247
8.
Marginal zone lymphoma of the colon: case series from a single center and SEER data review.
Leuk Lymphoma
; 63(5): 1160-1166, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927537
9.
Potency Meets Precision in Nano-optimized Chemotherapeutics.
Trends Biotechnol
; 39(10): 974-977, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33832781
10.
Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors.
Cancer Res
; 81(3): 763-775, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33177062
11.
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.
J Immunother Cancer
; 5: 3, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105370